Cryo-Cell International, Inc. – NASDAQ:CCEL
Cryo-Cell International stock price today
$4.695
-3.02
-39.18%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 3 hours
Cryo-Cell International stock price monthly change
+1.85%
month
Cryo-Cell International stock price quarterly change
+1.85%
quarter
Cryo-Cell International stock price yearly change
+33.10%
year
Cryo-Cell International key metrics
Market Cap | 62.15M |
Enterprise value | 73.77M |
P/E | -6.97 |
EV/Sales | 2.31 |
EV/EBITDA | -6.65 |
Price/Sales | 1.95 |
Price/Book | -6.51 |
PEG ratio | -1.81 |
EPS | -1.16 |
Revenue | 31.37M |
EBITDA | 4.21M |
Income | -9.73M |
Revenue Q/Q | 0.35% |
Revenue Y/Y | 1.51% |
Profit margin | -28.04% |
Oper. margin | -39.49% |
Gross margin | 73.66% |
EBIT margin | -39.49% |
EBITDA margin | 13.43% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCryo-Cell International stock price history
Cryo-Cell International stock forecast
Cryo-Cell International financial statements
| May 2023 | 7.77M | 220.97K | 2.84% |
|---|---|---|---|
| Aug 2023 | 7.86M | 680.56K | 8.65% |
| Nov 2023 | 7.87M | -11.19M | -142.06% |
| Feb 2024 | 7.85M | 556.24K | 7.08% |
| 2025 | 35.21M | 1.00M | 2.84% |
|---|
Analysts Price target
Financials & Ratios estimates
3.23%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | |
|---|---|
| 2020 | |
| 2021 | |
| 2022 | 20.74% |
| 2023 |
| May 2023 | 68757708 | 69.61M | 101.25% |
|---|---|---|---|
| Aug 2023 | 69796366 | 69.81M | 100.02% |
| Nov 2023 | 61220770 | 72.25M | 118.02% |
| Feb 2024 | 61710774 | 72.04M | 116.75% |
| May 2023 | 1.98M | -1.57M | -663.23K |
|---|---|---|---|
| Aug 2023 | 1.94M | -3.38M | 903.85K |
| Nov 2023 | 3.34M | -1.98M | -1.54M |
| Feb 2024 | -356.86K | -341.04K | 538.95K |
Cryo-Cell International alternative data
| Aug 2023 | 80 |
|---|---|
| Sep 2023 | 80 |
| Oct 2023 | 80 |
| Nov 2023 | 80 |
| Dec 2023 | 80 |
| Jan 2024 | 80 |
| Feb 2024 | 80 |
| Mar 2024 | 82 |
| Apr 2024 | 82 |
| May 2024 | 82 |
| Jun 2024 | 82 |
| Jul 2024 | 82 |
Cryo-Cell International other data
6.75%
-5.32%
of CCEL is owned by hedge funds
572.24K
-451.62K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2022 | 50391 | 56000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | PORTNOY DAVID director, 10 perc.. | Common Stock | 2 | $4.86 | $10 | ||
Purchase | PORTNOY DAVID director, 10 perc.. | Common Stock | 532 | $4.9 | $2,607 | ||
Purchase | PORTNOY DAVID director, 10 perc.. | Common Stock | 516 | $4.9 | $2,528 | ||
Purchase | PORTNOY DAVID director, 10 perc.. | Common Stock | 9,491 | $4.8 | $45,557 | ||
Sale | PORTNOY DAVID director, 10 perc.. | Common Stock | 6,000 | $4.81 | $28,860 | ||
Sale | PORTNOY DAVID director, 10 perc.. | Common Stock | 10,000 | $4.8 | $48,000 | ||
Purchase | PORTNOY DAVID director, 10 perc.. | Common Stock | 10,000 | $4.8 | $48,000 | ||
Sale | PORTNOY DAVID director, 10 perc.. | Common Stock | 10,000 | $4.8 | $48,000 | ||
Purchase | PORTNOY DAVID director, 10 perc.. | Common Stock | 3,000 | $4.8 | $14,400 | ||
Purchase | PORTNOY DAVID director, 10 perc.. | Common Stock | 3,000 | $4.77 | $14,310 |
Tuesday, 15 October 2024 | ||
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results | businesswire.com | |
Monday, 15 April 2024 | ||
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results | businesswire.com | |
Thursday, 12 October 2023 | ||
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results | businesswire.com | |
Friday, 14 July 2023 | ||
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results | businesswire.com | |
Friday, 21 April 2023 | ||
| Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results | businesswire.com | |
Friday, 11 February 2022 | ||
| Cryo-Cell International: A Stable Business Paired With An Upcoming Catalyst | Seeking Alpha |
-
What's the price of Cryo-Cell International stock today?
One share of Cryo-Cell International stock can currently be purchased for approximately $4.7.
-
When is Cryo-Cell International's next earnings date?
Unfortunately, Cryo-Cell International's (CCEL) next earnings date is currently unknown.
-
Does Cryo-Cell International pay dividends?
Yes, Cryo-Cell International pays dividends and its trailing 12-month yield is 3.24% with 0% payout ratio. The last Cryo-Cell International stock dividend of undefined was paid on 26 Sep 2025.
-
How much money does Cryo-Cell International make?
Cryo-Cell International has a market capitalization of 62.15M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.32% to 31.34M US dollars.
-
What is Cryo-Cell International's stock symbol?
Cryo-Cell International, Inc. is traded on the NASDAQ under the ticker symbol "CCEL".
-
What is Cryo-Cell International's primary industry?
Company operates in the Healthcare sector and Medical - Care Facilities industry.
-
How do i buy shares of Cryo-Cell International?
Shares of Cryo-Cell International can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Cryo-Cell International's key executives?
Cryo-Cell International's management team includes the following people:
- Mr. David I. Portnoy Chairman & Co-Chief Executive Officer(age: 62, pay: $602,090)
- Mr. Mark L. Portnoy Co-Chief Executive Officer & Director(age: 61, pay: $479,000)
- Mr. Oleg Mikulinsky Chief Information Officer(age: 52, pay: $258,330)
- Ms. Jill M. Taymans Chief Financial Officer & Vice President of Fin.(age: 55, pay: $201,500)
-
How many employees does Cryo-Cell International have?
As Jul 2024, Cryo-Cell International employs 82 workers.
-
When Cryo-Cell International went public?
Cryo-Cell International, Inc. is publicly traded company for more then 31 years since IPO on 4 Apr 1994.
-
What is Cryo-Cell International's official website?
The official website for Cryo-Cell International is cryo-cell.com.
-
Where are Cryo-Cell International's headquarters?
Cryo-Cell International is headquartered at 700 Brooker Creek Boulevard, Oldsmar, FL.
-
How can i contact Cryo-Cell International?
Cryo-Cell International's mailing address is 700 Brooker Creek Boulevard, Oldsmar, FL and company can be reached via phone at +81 37492100.
Cryo-Cell International company profile:
Cryo-Cell International, Inc.
cryo-cell.comExchange:
NASDAQ
Full time employees:
82
Industry:
Medical - Care Facilities
Sector:
Healthcare
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
700 Brooker Creek Boulevard
Oldsmar, FL 34677
Oldsmar, FL 34677
CIK: 0000862692
ISIN: US2288951088
CUSIP: 228895108
